Stocks TelegraphStocks Telegraph
Stock Ideas

ATRI Company Profile and Key Details

NASDAQ : ATRI

Atrion

$459.92
0.26+0.06%
At Close 4:00 PM
Not Actively Trading
59.23
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Atrion Corporation (ATRI) stock surged +0.06%, trading at $459.92 on NASDAQ, up from the previous close of $459.66. The stock opened at $459.75, fluctuating between $459.75 and $460.26 in the recent session.

Stock Snapshot

459.66
Prev. Close
809.44M
Market Cap
459.75
Day Low
64.50490883590463
P/E Ratio
7.13
EPS (TTM)
-1.31
Cash Flow per Share
459.75
Open
1.76M
Number of Shares
460.26
Day High
93.53%
Free Float in %
138.01
Book Value
29.52K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Aug 30, 2024459.92459.92459.92459.920
Aug 29, 2024459.92459.92459.92459.920
Aug 28, 2024459.92459.92459.92459.920
Aug 27, 2024459.92459.92459.92459.920
Aug 26, 2024459.92459.92459.92459.920
Aug 23, 2024459.92459.92459.92459.920
Aug 22, 2024459.92459.92459.92459.920
Aug 21, 2024459.92459.92459.92459.920
Aug 20, 2024459.75460.26459.75459.9229.73K
Aug 19, 2024460.00460.00459.60459.6619.99K
Aug 16, 2024459.58460.00459.58459.8527.64K
Aug 15, 2024459.66459.66459.45459.4516.63K
Aug 14, 2024459.70459.70459.41459.4611.2K
Aug 13, 2024459.25459.62459.25459.4826K
Aug 12, 2024459.12459.14459.01459.0215.18K
Aug 09, 2024459.15459.18458.77458.7714.2K
Aug 08, 2024459.30459.34458.62458.6229.22K
Aug 07, 2024458.50459.17458.50458.5123.87K
Aug 06, 2024458.11459.36458.03458.5022.41K
Aug 05, 2024457.75458.83457.50458.2530.84K

Contact Details

Allen, TX 75002-4211

United States

https://www.atrioncorp.com972 390 9800

About Company

Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.

Company Information

Employees712
Beta0.69
Sales or Revenue$169.33M
5Y Sales Change%0.169%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Instruments & Supplies

Company Overview

Atrion Corporation (NASDAQ:ATRI) closed at $459.92 USD, gaining $0.26 (0.06%) from the previous close of $459.66. The stock is currently mid-range between its 52-week high and low $274.98 and $503.24. With a market capitalization of about $809.44 million, Atrion Corporation is classified as a small-cap and shows lower-than-market volatility (beta ~0.69). Key stats such as the average daily volume over the past year has been around 27.59 thousand shares, in line with its 52-week average. Headquartered in Allen, TX, Atrion Corporation operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO David A. Battat, the company employs approximately 712 people and listed since March 18, 1980. Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond.

Technical Performance

ATRI has shown mixed momentum, gaining 0.02% over the past week and -0.62% over the past quarter, though year-to-date performance is up 21.42%. Short-term trend indicators are bearishly aligned (SMA20 0.27%, SMA50 0.87%, SMA200 14.94%). The stock’s 14-day RSI is 64.5 (firm momentum), while the ATR of 1.3 points to tighter daily ranges. The stock remains sitting in the mid-range of its 52-week band, trading -8.61% below its high and over 67.26% above its low.

Valuation Metrics

Atrion Corporation trades at a P/E ratio of 41.74, slightly above the S&P 500 average, with a price-to-sales ratio of 4.78 and a price-to-book ratio of 3.33 trading at moderately above to book value. The P/FCF stands at -349.95, also above market averages.

Dividend & Fair Value

Atrion Corporation last paid a dividend of 8.8 per share, this equals a trailing yield of roughly 1.92%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $120.30. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Atrion Corporation generated EPS of $7.13 over the past year. Five-year average earnings growth is -9.78%.

Shareholding & Insider Activity

Atrion Corporation has 1.76 million shares outstanding. The public float is 1.65 million shares, elevated short interest at 3.79% of float. This equals 44.46 thousand shares. The short ratio is 2.04 days. Institutional investors hold 93.78% of the float. Insiders own 23.37%. BATTAT EMILE A holds 149.80 thousand shares, Battat David A has 39.40 thousand shares and MORGAN HUGH J JR has 17.94 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Atrion generated $169.33M in revenue, or $96.15 per share. Gross margin was 36.84%, operating margin 13.33%, and net profit margin 11.46%. Returns are modest, with ROA at 7.44% and ROE at 7.99%.
On valuation metrics, Atrion trades at a P/E of 41.74, P/S of 4.78 and P/B of 3.33. The current ratio is 9.09 and quick ratio is 2.57. Operationally, the company’s inventory turnover is 1.30 and cash conversion cycle is 307.95 days. Debt-to-equity is 0.00, supported by a cash flow-to-debt ratio of 83.36.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Atrion posted revenue of $169.33M, down slightly from $183.51M in the prior quarter. Gross profit was $62.39M (margin 36.84%). Operating income was $22.58M (margin 13.3%). Net income was$19.41M (EPS $11.02).
The company ended the quarter with $6.26M in cash and short-term investments, a total debt of $0.00, and net debt of - $3.57M. Total assets were $260.83M, with equity of $242.89M. Financials further reflected stability, with operating cash flow of $20.01M, free cash flow of - $2.31M, and capital expenditures of - $22.32M.

Price Forecast & Outlook

Our AI price prediction model suggests that Atrion Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.01%, with price expected at $459.89 by September 13, 2024, within a range of $453.17 to $467.40 3-Month Outlook: Projected fall of -26.51%, reaching $338.00 by November 21, 2024, with a range of $307.16 to $358.47. 1-Year Outlook: Projected loss of -26.12%, with price at $339.79 by August 29, 2025, within a range of $316.04 to $373.37.

Key Takeaways

Atrion Corporation (NASDAQ:ATRI) shares are up 21.42% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Atrion Corporation trading at a premium to the broader market with a P/E of 41.74. Analyst sentiment is cautious, with the majority of ratings in Sell territory and a mean price target of $300.00, suggesting -34.77% downside. Our AI forecast model points to short-term weakness (-0.01% over two weeks), a medium-term fall (-26.51% over three months), and a longer-term loss (-26.12% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Atrion Corporation (ATRI) stock price?
Atrion Corporation (NASDAQ: ATRI) stock price is $459.92 in the last trading session. During the trading session, ATRI stock reached the peak price of $460.26 while $459.75 was the lowest point it dropped to. The percentage change in ATRI stock occurred in the recent session was 0.06% while the dollar amount for the price change in ATRI stock was $0.26.
ATRI's industry and sector of operation?
The NASDAQ listed ATRI is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Atrion Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ATRI?
Ms. Cindy Ferguson
Vice President, Chief Financial Officer, Sec. & Treasurer
Mr. David A. Battat
Pres & Chief Executive Officer
Mr. Jeffery Strickland
Chief Financial Officer, Vice President, Treasurer & Sec.
Mr. Emile A. Battat
Executive Chairman
How ATRI did perform over past 52-week?
ATRI's closing price is 67.26% higher than its 52-week low of $274.98 where as its distance from 52-week high of $503.24 is -8.61%.
How many employees does ATRI have?
Number of ATRI employees currently stands at 712.
Link for ATRI official website?
Official Website of ATRI is: https://www.atrioncorp.com
How do I contact ATRI?
ATRI could be contacted at phone 972 390 9800 and can also be accessed through its website. ATRI operates from One Allentown Parkway, Allen, TX 75002-4211, United States.
How many shares of ATRI are traded daily?
ATRI stock volume for the day was 29.52K shares. The average number of ATRI shares traded daily for last 3 months was 27.6K.
What is the market cap of ATRI currently?
The market value of ATRI currently stands at $809.44M with its latest stock price at $459.92 and 1.76M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph